crescentis capital will hold its 33rd Annual General Meeting (AGM) on Wednesday, August 26, 2026, at 12:00 Noon via Video Conferencing/Other Audio Visual Means (OAVM). The meeting aims to secure shareholder approval for critical governance matters, including the re-appointment of key executives with revised compensation structures and a substantial employee stock option grant, signaling the company’s focus on stabilizing leadership as it transitions into active lending operations.

The Board of Directors has recommended the re-appointment of Mr. Subba Rao Veeravenkata Meka as Managing Director and Mr. Bhavanam Ruthvik Reddy as Whole-Time Director & Chief Executive Officer for a period of five years, commencing from September 12, 2026, and ending on September 11, 2031. Both executives are liable to retire by rotation but have offered themselves for re-appointment following the recommendation of the Nomination and Remuneration Committee.

Executive Remuneration Revisions

The proposed remuneration packages reflect an increase in base salaries for both roles, effective from the start of their new terms. The revisions are structured in accordance with Schedule V of the Companies Act, 2013, allowing for payment even in the event of inadequate profits.

In addition to basic salaries, both executives are entitled to perquisites including medical reimbursement, leave travel allowance, and house maintenance, subject to statutory ceilings. They will also receive annual performance incentives determined by the Board or the Nomination and Remuneration Committee, payable after the adoption of annual accounts. An annual increment of up to 10% on the monthly basic salary may be granted based on performance evaluation.

Employee Stock Option Grant

A special resolution seeks shareholder approval for the grant of up to 10,00,000 Employee Stock Options (ESOs) to Mr. Subba Rao Veeravenkata Meka under the Crescentis Capital Limited Employees' Stock Option Scheme, 2025 (CCL ESOS 2025). This grant exceeds one percent of the issued capital, necessitating specific shareholder consent under Regulation 6(3)(d) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The Nomination and Remuneration Committee, acting as the Compensation Committee, has already approved the initial grant of 5,00,000 ESOs. The resolution authorizes the Committee to grant the remaining balance of up to 5,00,000 ESOs in one or more tranches during the same or subsequent financial years, subject to the aggregate limit of 10,00,000 options. Each vested option entitles the grantee to subscribe to one equity share of face value ₹10, ranking pari passu with existing shares.

Voting and Meeting Details

Shareholders holding shares as of the cut-off date, Friday, August 21, 2026, are eligible to vote. Remote e-voting will be facilitated by National Securities Depository Limited (NSDL) from August 22, 2026, at 09:00 AM to August 25, 2026, at 05:00 PM. Members who cast their votes remotely may attend the AGM but cannot vote again during the meeting. Proxy appointments are not available for this AGM, though body corporates may appoint authorized representatives.

The company, formerly known as Som Datt Finance Corporation Limited, changed its name effective January 6, 2026, following shareholder approval via postal ballot. The AGM notice and Annual Report for FY2025-26 were dispatched electronically on July 30, 2026, pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Crescentis Capital Limited disclosed an inter-se transfer of shares within its promoter group, involving a gift of 1.76% of the company's equity share capital. Dr. Bhaskara Rao Bollineni transferred 3,00,000 equity shares to Mr. Bhavanam Ruthvik Reddy on June 24, 2026, via an off-market transaction. The transfer was executed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The transaction represents a redistribution of shareholding within the promoter group and does not alter the aggregate holding of the promoters. Consequently, the total promoter and promoter group shareholding remains unchanged. The disclosures regarding the transfer were submitted to BSE Limited on June 26, 2026.

Shareholding Details

The transfer modified the individual stakes of the two promoters. Dr. Bhaskara Rao Bollineni's holding decreased from 68.80% to 67.04%, while Mr. Bhavanam Ruthvik Reddy's stake increased from 6.17% to 7.94%.

Transaction Breakdown

The specific details of the inter-se transfer are outlined below:

The equity share capital of the company remains at 1,70,13,549 equity shares of ₹10 each before and after the transaction.